Don’t Judge a Ketamine Infusion on the Same Day. New Brain Scans Show Why Tomorrow Matters
A patient who feels no different the afternoon of a ketamine infusion has not learned anything yet. A brain imaging study in Translational Psychiatry adds to the case, and an aggregator picked it up this month.
Researchers in Vienna scanned 28 healthy adults five hours after an infusion and found no change in reward circuits. Other imaging work finds changes the next day. The clinical response is commonly described as peaking around 24 hours.
For a clinic that points at three practical things. When to check in, what to say before the patient leaves, and how to answer a headline that says ketamine did nothing.
We can save your ketamine clinic a lot of money. Here is how. The HealingMaps GPO, the first built for the ketamine industry, gets members 15 to 20 percent off malpractice and liability premiums, 40 percent or more off medical supplies, discounted LegitScript certification, and 20 to 30 percent off HIPAA compliant payment processing. Joining is free and carries no obligation. See how much your clinic can save →
| Key Takeaway | Detail |
|---|---|
| The takeaway for a clinic | Judge an infusion the next day, not the same afternoon |
| What to tell patients | Relief can start within hours, but the usual peak is around 24 hours. The afternoon is not the verdict |
| The new evidence | 28 healthy adults scanned about 5 hours after 0.5 mg/kg ketamine. No change in reward circuits |
| Why that fits | Other imaging finds changes at 40 minutes, 2 hours and 24 hours. Five hours sits in a gap |
| When a patient cites it | Ask who was studied and when they were measured. Here, healthy volunteers at five hours |
| The limit | Brain scans in healthy people, not symptom scores in patients. The authors say so themselves |
| Worth knowing | Every participant on ketamine who answered guessed correctly what they had been given |
What this changes in a clinic
Move the check-in to the next day. The paper’s own background section says antidepressant effects can emerge within two to four hours, with the maximal clinical effect commonly seen around 24 hours. A clinic that only asks how the patient feels at discharge is asking before the usual peak. A short call or message the next day catches the response closer to it.
Say it before the patient leaves. A patient who feels nothing by dinner may decide the infusion failed. Telling them in advance that the day after is the better read costs nothing. It also heads off the discouraged phone call.
Have an answer for the headline. A study that finds nothing is not the same as a treatment that does nothing. Two questions sort it out. Who was studied, and when were they measured? Here the answers are healthy volunteers with a mean age of 23.6, at five hours.
None of this changes dosing. It changes when a practice looks and what it says.
What the study actually found
The design was a single-blind, placebo-controlled crossover. Each participant got 0.5 mg/kg racemic ketamine over a 40 minute infusion in one session. In another session, about two weeks later, they got saline.
Roughly five hours after each infusion they ran the Monetary Incentive Delay task in the scanner. It is the standard way to separate reward anticipation from reward delivery.
Nothing separated. Not in the predefined regions, not across the whole brain, and not in reaction times on the task itself. Individual blood levels of the drug did not predict brain activation either.
Thirty six people completed the protocol. Two were dropped for motion during scanning, and others for missing or irregular plasma curves. That left 28.
Why a null result here is not bad news
Everyone in this study was healthy. Nobody had a current or past psychiatric diagnosis.
Reward circuits that are working normally have nothing for an antidepressant to repair. The authors close the paper by saying exactly that. They write that the effects may be more prominent in clinical populations with pre-existing reward dysfunction.
The same paper cites earlier work in remitted depression. There, ketamine did move the nucleus accumbens and putamen two hours after infusion. Patients and healthy volunteers are not the same experiment.
Five hours sits in a gap
Line the imaging literature up by time and a pattern appears that no single study shows on its own.
| Time after infusion | What imaging has found | In whom |
|---|---|---|
| 20 minutes | Increased prefrontal to hippocampal connectivity | Healthy volunteers |
| 40 minutes | Reduced ventral striatal activation during reward anticipation | Healthy volunteers |
| 2 hours | Increased nucleus accumbens and putamen during reward feedback | Remitted depression |
| 5 hours | No detectable effect on reward processing | Healthy volunteers |
| 24 hours | Reduced habenula response to unpleasant stimuli | Healthy volunteers |
| 2 days | Decreased fronto-striatal connectivity | Healthy volunteers |
Acute dissociation has resolved by about two hours. The next cluster of findings sits a day out. The five hour scan landed between them.
We covered the far end of that curve when two teams both landed on the day after the infusion. This study is the same argument from the other direction.
Nobody was actually blinded
One more detail is useful when a patient asks how certain the research is. Of the participants who answered, every single one in the ketamine condition correctly identified what they had been given.
In the placebo condition 85.7 percent guessed correctly. Average confidence was above 89 out of 100 in both conditions.
A saline placebo cannot hide a dissociative drug. That is a structural problem for every trial in this field, not a flaw in this one.
What this does not prove
The study did not test patients, and it did not measure symptoms. It measured brain activation during a money task in healthy young adults.
So the next-day advice does not come from these scans alone. It rests on the clinical timing the authors cite, and the scans are consistent with it.
We have tracked the same question from the response side. Responders carried a different immune signature before their first dose, and brain response appeared to depend on the patient.
Patients comparing supervised options can start with our directory of verified ketamine clinics.
This article is for informational purposes and is not medical advice. The study described enrolled healthy volunteers, not patients, and its findings do not establish whether ketamine relieves anhedonia in depression.
